Evidence‐ and Consensus‐Based Recommendations for the Screening, Diagnosis, and Management of Secondary Hypogammaglobulinemia in Patients With Systemic Autoimmune Rheumatic Diseases by the Taiwan College of Rheumatology Experts
International Journal of Rheumatic Diseases · 2025-06 · 28 (6)
DOI: 10.1111/1756-185x.70310 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 16.06.2025. Verfasst von Yen-Po Tsao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Agammaglobulinemia, Rheumatic Diseases, Autoimmune Diseases, Evidence-Based Medicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Secondary hypogammaglobulinemia (SHG) is characterized by reduced serum immunoglobulin (Ig) levels and is typically caused by immunosuppressive therapy or certain diseases. Patients with systemic autoimmune rheumatic diseases (SARDs) and hematological malignancies are particularly susceptible to developing SHG due to underlying diseases and the use of immunosuppressive medications, such as B‐cell‐targeted agents. Consequently, SHG significantly contributes to increased risks of severe infections and mortality in SARDs patients. Considering the lack of a unified strategy for managing SHG, the Taiwan College of Rheumatology (TCR) aimed to formulate consensus recommendations for the screening, diagnosis, and management of SHG. These recommendations were developed based on emerging evidence during a face‐to‐face meeting of the TCR committee (nine immunologists and rheumatologists), and utilizing the modified Delphi process. This meeting involved a comprehensive review of the current evidence, using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Thirteen consensus recommendations were developed to emphasize the importance of early detection and optimal treatment of SHG. Furthermore, effective prevention of infections through risk assessment alongside timely and regular monitoring of IgG levels was highlighted. The recommendations also included anti‐infective therapies and intravenous Ig replacement, offering valuable guidance to rheumatologists in managing SHG. This consensus will be regularly updated as newer evidence emerges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy, Immunology and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Holistic and Multidisciplinary Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan.
- Division of Translational Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
ORCID-Profile: Hsin-Hua Chen, Ko-Jen Li, Tien-Tsai Cheng, Chun-Chi Lu, Der-Yuan Chen
Zitieren
APA
Tsao, Y. P., Chen, H. H., Hsieh, T. Y., Li, K. J., Yu, K. H., Cheng, T. T., Tseng, J. C., Lu, C. C., & Chen, D. Y. (2025). Evidence‐ and Consensus‐Based Recommendations for the Screening, Diagnosis, and Management of Secondary Hypogammaglobulinemia in Patients With Systemic Autoimmune Rheumatic Diseases by the Taiwan College of Rheumatology Experts. International Journal of Rheumatic Diseases, 28(6). https://doi.org/10.1111/1756-185x.70310
Vancouver
Tsao YP, Chen HH, Hsieh TY, Li KJ, Yu KH, Cheng TT, et al. Evidence‐ and Consensus‐Based Recommendations for the Screening, Diagnosis, and Management of Secondary Hypogammaglobulinemia in Patients With Systemic Autoimmune Rheumatic Diseases by the Taiwan College of Rheumatology Experts. International Journal of Rheumatic Diseases. 2025;28(6). doi:10.1111/1756-185x.70310
BibTeX
@article{Tsao2025,
author = {Tsao, Yen-Po and Chen, Hsin-Hua and Hsieh, Tsu-Yi and Li, Ko-Jen and Yu, Kuang-Hui and Cheng, Tien-Tsai and Tseng, Jui-Cheng and Lu, Chun-Chi and Chen, Der-Yuan},
title = {Evidence‐ and Consensus‐Based Recommendations for the Screening, Diagnosis, and Management of Secondary Hypogammaglobulinemia in Patients With Systemic Autoimmune Rheumatic Diseases by the Taiwan College of Rheumatology Experts},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
volume = {28},
number = {6},
doi = {10.1111/1756-185x.70310}
}
EUVIMED